Trials / Completed
CompletedNCT01951742
Dose Finding Study In Subjects With Crow's Feet
Dose Finding Study of Botulinum Neurotoxin Type A In Subjects With Crow's Feet (Lateral Canthal Lines)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Anterios Inc. · Industry
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ANT-1401 | Active |
| BIOLOGICAL | Vehicle | Vehicle |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2013-12-01
- Completion
- 2014-01-01
- First posted
- 2013-09-27
- Last updated
- 2014-05-29
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01951742. Inclusion in this directory is not an endorsement.